{"id":"https://openalex.org/W2144193100","doi":"https://doi.org/10.2337/dc12-2718","title":"Effects of Adding Linagliptin to Basal Insulin Regimen for Inadequately Controlled Type 2 Diabetes","display_name":"Effects of Adding Linagliptin to Basal Insulin Regimen for Inadequately Controlled Type 2 Diabetes","alternate_titles":[],"publication_year":2013,"publication_date":"2013-11-13","ids":{"openalex":"https://openalex.org/W2144193100","doi":"https://doi.org/10.2337/dc12-2718","mag":"2144193100","pmid":"https://pubmed.ncbi.nlm.nih.gov/24062327","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3836100"},"language":"en","primary_location":{"id":"doi:10.2337/dc12-2718","doi":"https://doi.org/10.2337/dc12-2718","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc12-2718","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2144193100"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.2337/dc12-2718","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028953583","display_name":"Hannele Yki\u2010J\u00e4rvinen","orcid":"https://orcid.org/0000-0001-6766-1549","observed_orcids":["https://orcid.org/0000-0001-6766-1549"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I4210101041","display_name":"Minerva Foundation","ror":"https://ror.org/0152xm391","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I4210101041"]}],"countries":["FI"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Hannele Yki-J\u00e4rvinen","raw_affiliation_strings":["Department of Medicine, University of Helsinki, Helsinki and Minerva Foundation Institute for Medical Research, Helsinki, Finland","1Department of Medicine, University of Helsinki, Helsinki and Minerva Foundation Institute for Medical Research, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Helsinki, Helsinki and Minerva Foundation Institute for Medical Research, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210101041"]},{"raw_affiliation_string":"1Department of Medicine, University of Helsinki, Helsinki and Minerva Foundation Institute for Medical Research, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210101041"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045489578","display_name":"Julio Rosenstock","orcid":"https://orcid.org/0000-0001-8324-3275","observed_orcids":["https://orcid.org/0000-0001-8324-3275"]},"institutions":[{"id":"https://openalex.org/I2800474951","display_name":"Medical City Dallas Hospital","ror":"https://ror.org/059rc1n32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800474951"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julio Rosenstock","raw_affiliation_strings":["Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas","2Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas","institution_ids":["https://openalex.org/I2800474951"]},{"raw_affiliation_string":"2Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040184364","display_name":"Santiago Dur\u00e1n-Garcia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79238269","display_name":"Universidad de Sevilla","ror":"https://ror.org/03yxnpp24","country_code":"ES","type":"education","lineage":["https://openalex.org/I79238269"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Santiago Dur\u00e1n-Garcia","raw_affiliation_strings":["Valme Hospital Medical School, University of Sevilla, Seville, Spain","3Valme Hospital Medical School, University of Sevilla, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valme Hospital Medical School, University of Sevilla, Seville, Spain","institution_ids":["https://openalex.org/I79238269"]},{"raw_affiliation_string":"3Valme Hospital Medical School, University of Sevilla, Seville, Spain","institution_ids":["https://openalex.org/I79238269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077360595","display_name":"Sabine Pinnetti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sabine Pinnetti","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","4Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"4Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022968333","display_name":"Sudipta Bhattacharya","orcid":"https://orcid.org/0000-0002-2155-9773","observed_orcids":["https://orcid.org/0000-0002-2155-9773"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sudipta Bhattacharya","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","4Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"4Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003455767","display_name":"Sandra Thiemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sandra Thiemann","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany","5Boehringer Ingelheim Pharma GmbH and Co. KG, Ingelheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"5Boehringer Ingelheim Pharma GmbH and Co. KG, Ingelheim, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110708868","display_name":"Sanjay Dhanji Patel","orcid":"https://orcid.org/0000-0003-2739-9448","observed_orcids":["https://orcid.org/0000-0003-2739-9448"]},"institutions":[{"id":"https://openalex.org/I4210112752","display_name":"Boehringer Ingelheim (United Kingdom)","ror":"https://ror.org/01jnnpe14","country_code":"GB","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210112752"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sanjay Patel","raw_affiliation_strings":["Boehringer Ingelheim Ltd., Bracknell, U.K","6Boehringer Ingelheim Ltd., Bracknell, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Ltd., Bracknell, U.K","institution_ids":["https://openalex.org/I4210112752"]},{"raw_affiliation_string":"6Boehringer Ingelheim Ltd., Bracknell, U.K","institution_ids":["https://openalex.org/I4210112752"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113554665","display_name":"Hans\u2010Juergen Woerle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hans-Juergen Woerle","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany","5Boehringer Ingelheim Pharma GmbH and Co. KG, Ingelheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"5Boehringer Ingelheim Pharma GmbH and Co. KG, Ingelheim, Germany","institution_ids":["https://openalex.org/I1330995197"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5028953583"],"corresponding_institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210101041"],"apc_list":null,"apc_paid":null,"fwci":13.7925,"has_fulltext":true,"cited_by_count":142,"citation_normalized_percentile":{"value":0.99340376,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"36","issue":"12","first_page":"3875","last_page":"3881"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/linagliptin","display_name":"linagliptin","score":1.0},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.9340000152587891},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9879999756813049},{"id":"https://openalex.org/keywords/inadequate-glycemic-control","display_name":"inadequate glycemic control","score":0.8560000061988831},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8730000257492065},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8999999761581421},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8220000267028809},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.8550000190734863},{"id":"https://openalex.org/keywords/insulin-dose-adjustment","display_name":"insulin dose adjustment","score":0.7950000166893005},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9110000133514404},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":1.0}],"concepts":[{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.9829691648483276},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8695071935653687},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.736868679523468},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6866122484207153},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6176243424415588},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6116753816604614},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5887284278869629},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.5875916481018066},{"id":"https://openalex.org/C2778024521","wikidata":"https://www.wikidata.org/wiki/Q55639806","display_name":"Basal (medicine)","level":3,"score":0.5579431653022766},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.549182116985321},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4947959780693054},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4849388897418976},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.4828251302242279},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4067142605781555},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3709067404270172},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069476","descriptor_name":"Linagliptin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.2337/dc12-2718","doi":"https://doi.org/10.2337/dc12-2718","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc12-2718","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3836100","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3836100/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3836100/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"Text"},{"id":"pmid:24062327","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24062327","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.789.6616","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.789.6616","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/9a/74/3875.PMC3836100.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.851.3872","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.851.3872","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://care.diabetesjournals.org/content/early/2013/09/16/dc12-2718.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.860.5474","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.860.5474","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://care.diabetesjournals.org/content/36/12/3875.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2337/dc12-2718","doi":"https://doi.org/10.2337/dc12-2718","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc12-2718","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320315142","display_name":"MannKind Corporation","ror":"https://ror.org/02vbfm330"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2144193100.pdf","grobid_xml":"https://content.openalex.org/works/W2144193100.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1549103904","https://openalex.org/W1597594434","https://openalex.org/W1970406523","https://openalex.org/W1994021369","https://openalex.org/W2009999012","https://openalex.org/W2038953694","https://openalex.org/W2059245135","https://openalex.org/W2060124483","https://openalex.org/W2074925580","https://openalex.org/W2100987099","https://openalex.org/W2111876001","https://openalex.org/W2113297547","https://openalex.org/W2114417910","https://openalex.org/W2121242002","https://openalex.org/W2122130517","https://openalex.org/W2126781806","https://openalex.org/W2128766821","https://openalex.org/W2149194615","https://openalex.org/W2159205789","https://openalex.org/W2162037642","https://openalex.org/W2163457223","https://openalex.org/W2172193326"],"related_works":["https://openalex.org/W2083832616","https://openalex.org/W2178077567","https://openalex.org/W1994521895","https://openalex.org/W3093184674","https://openalex.org/W2074142099","https://openalex.org/W1847388060","https://openalex.org/W2322149290","https://openalex.org/W1826263849","https://openalex.org/W2313391768","https://openalex.org/W2006925617"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,94,102,165],"efficacy":[4],"and":[5,141,148,209],"long-term":[6],"safety":[7,113],"of":[8,34,121,133,195],"linagliptin":[9,62,147,179,199,205,227],"added":[10,235],"to":[11,41,58,88,109,118,157,167,236,245],"basal":[12,21,46,73,169,237],"insulins":[13],"in":[14,105,189],"type":[15],"2":[16],"diabetes":[17],"inadequately":[18],"controlled":[19],"on":[20,45],"insulin":[22,47,74,238],"with":[23,51,61,146],"or":[24,49,67,250],"without":[25,247],"oral":[26],"agents.":[27],"RESEARCH":[28],"DESIGN":[29],"AND":[30],"METHODS:":[31],"A":[32],"total":[33],"1,261":[35],"patients":[36],"(HbA1c":[37],"\u22657.0%":[38],"[53":[39],"mmol/mol]":[40],"\u226410.0%":[42],"[86":[43],"mmol/mol])":[44],"alone":[48],"combined":[50],"metformin":[52],"and/or":[53],"pioglitazone":[54],"were":[55,216],"randomized":[56],"(1:1)":[57],"double-blind":[59],"treatment":[60,203],"5":[63],"mg":[64],"once":[65],"daily":[66],"placebo":[68,182,201,207,214,230,246],"for":[69,79],"\u226552":[70],"weeks.":[71,123],"The":[72,97,112],"dose":[75],"was":[76,101,172],"kept":[77],"unchanged":[78,224],"24":[80],"weeks":[81],"but":[82],"could":[83],"thereafter":[84],"be":[85],"titrated":[86],"according":[87],"fasting":[89],"plasma":[90],"glucose":[91],"levels":[92],"at":[93],"investigators'":[95],"discretion.":[96],"primary":[98],"end":[99],"point":[100],"mean":[103],"change":[104],"HbA1c":[106,128,192],"from":[107,130],"baseline":[108,132],"week":[110,126],"24.":[111],"analysis":[114],"incorporated":[115],"data":[116],"up":[117],"a":[119,131],"maximum":[120],"110":[122],"RESULTS:":[124],"At":[125],"24,":[127,198],"changed":[129],"8.3%":[134],"(67":[135],"mmol/mol)":[136,140,145],"by":[137,142],"-0.6%":[138],"(-6.6":[139],"0.1%":[143],"(1.1":[144],"placebo,":[149],"respectively":[150],"(treatment":[151],"difference":[152],"-0.65%":[153],"[95%":[154],"CI":[155],"-0.74":[156],"-0.55]":[158],"[-7.1":[159],"mmol/mol];":[160],"P":[161,185],"<":[162,186],"0.0001).":[163],"Despite":[164],"option":[166],"uptitrate":[168],"insulin,":[170],"it":[171],"adjusted":[173],"only":[174],"slightly":[175],"upward":[176],"(week":[177,197,225],"52,":[178,226],"2.6":[180],"IU/day,":[181],"4.2":[183],"IU/day;":[184],"0.003),":[187],"resulting":[188],"no":[190],"further":[191],"improvements.":[193],"Frequencies":[194],"hypoglycemia":[196,249],"22.0%,":[200],"23.2%;":[202],"end,":[204],"31.4%,":[206],"32.9%)":[208],"adverse":[210],"events":[211],"(linagliptin":[212],"78.4%,":[213],"81.4%)":[215],"similar":[217],"between":[218],"groups.":[219],"Mean":[220],"body":[221,251],"weight":[222],"remained":[223],"-0.30":[228],"kg,":[229],"-0.04":[231],"kg).":[232],"CONCLUSIONS:":[233],"Linagliptin":[234],"therapy":[239],"significantly":[240],"improved":[241],"glycemic":[242],"control":[243],"relative":[244],"increasing":[248],"weight.":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2144193100","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":28},{"year":2015,"cited_by_count":26},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
